Imagerie cérébrale dans les syndromes parkinsoniens
- PMID: 28040345
- DOI: 10.1016/j.lpm.2016.09.025
Imagerie cérébrale dans les syndromes parkinsoniens
Abstract
Role of brain imaging for Parkinsonism T brain MRI is normal in Pakinson's disease. Brain MRI is useless when clinical presentation is typical of idiopathic Parkinson's disease. Brain MRI is the exam of choice for differentiating idiopathic Parkinson's disease and atypical parkinsonism. DATscan* confirms or rules out dopaminergic degeneration but does not separate idiopathic Parkinson's disease from Parkinson "plus" syndromes. FDG PET is helpful to separate idiopathic Parkinson's disease from Parkinson "plus" syndromes.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.
Similar articles
-
[Usefulness of SPECT and MRI in the diagnosis of atypical parkinsonism].Tidsskr Nor Laegeforen. 2001 Nov 30;121(29):3399-403. Tidsskr Nor Laegeforen. 2001. PMID: 11826785 Norwegian.
-
What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective.Parkinsonism Relat Disord. 2019 Feb;59:93-100. doi: 10.1016/j.parkreldis.2018.08.016. Epub 2018 Aug 30. Parkinsonism Relat Disord. 2019. PMID: 30181086 Review.
-
Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.Neurophysiol Clin. 2001 Oct;31(5):321-40. doi: 10.1016/s0987-7053(01)00273-8. Neurophysiol Clin. 2001. PMID: 11817273 Review.
-
The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.J Neurol. 2015 Sep;262(9):2154-63. doi: 10.1007/s00415-015-7830-4. Epub 2015 Jun 30. J Neurol. 2015. PMID: 26122543
-
Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice.Mov Disord. 2003 Oct;18 Suppl 7:S16-21. doi: 10.1002/mds.10573. Mov Disord. 2003. PMID: 14531041 Review.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources